ArticleJournal of general internal medicine2026
Prevalence and Treatment of Anxiety and Depression Among US Healthcare Workers, 2021-2024.
Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHealthcare workers (HCWs) face high levels of psychological distress due to workplace stressors, but there is a paucity of evidence on the prevalence and treatment of anxiety and depression among HCWs.
objectiveTo examine the prevalence and treatment of self-reported anxiety and depression among HCWs.
designRetrospective cross-sectional study using nationally representative data from the 2021-2024 National Health Interview Survey (NHIS).
participants76,800 adults aged 18-64 years old. EXPOSURE: The primary exposure was HCW status, categorized by self-report. MAIN MEASURES: The primary outcomes were self-reported anxiety and depression. The secondary outcome was self-reported untreated anxiety or depression. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression models. KEY
resultsAmong 76,800 participants (59.0% aged 18-44, 50.4% female, and 58.9% non-Hispanic White), self-reported anxiety (23.3% vs 19.1%, p < 0.001) and depression (22.3% vs 18.9%, p < 0.001) were more common among HCWs than non-HCWs. Among individuals with self-reported anxiety or depression, HCWs were more likely to report untreated anxiety (72.1% vs 64.9%, p < 0.001) and untreated depression (67.2% vs 60.7%, p < 0.001), respectively. Anxiety and depression increased from 2021-2024 for HCWs (both p < 0.001). In multivariate regression, compared with non-HCWs, HCWs had higher odds of self-reported anxiety (OR: 1.21, 95% CI: 1.12-1.31) and depression (OR: 1.20, 95% CI: 1.11-1.29). HCWs had increased odds of self-reported untreated anxiety (OR: 1.28, 95% CI: 1.12-1.46) and depression (OR: 1.25, 95% CI: 1.10-1.42) among adults with self-reported anxiety or depression, respectively.
conclusionsIn this study, HCW status was associated with self-reported anxiety and depression, as well as lower rates of treatment. The prevalence of anxiety and depression significantly increased over the study period. These findings underscore the importance of structural interventions in protecting the mental well-being of the healthcare workforce.
Identifiers
42113331What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.